The call for abstracts is now open. Abstracts for oral presentations and posters are invited in areas relevant to the work of Cochrane, Guidelines International Network (G-I-N), Campbell Collaboration, Joanna Briggs Institute, and the International Society for Evidence-based Health Care (ISEHC) as well as evidence-based practice, policy, methodology, and advocacy.
Submissions are invited in the following categories:
- Evidence production: Abstracts concerning primary research production
- Priority setting for primary research to meet global priorities
- Global health and equity
- Real world evidence (pragmatic trials, big data)
- Improving conduct and reporting of primary research (including teaching and learning)
- Consumer and patient involvement in primary research
- Funding primary research
- Evidence synthesis: Abstracts concerning different forms of research synthesis: overviews, scoping reviews, systematic reviews, etc.
- Priority setting for syntheses to meet global priorities
- Methods for conducting syntheses (including different evidence, searching and information retrieval,
- statistics, assessing methodological quality)
- Improving conduct and reporting of syntheses (including teaching and learning)
- Synthesis creation, publication and updating in the digital age
- Consumer and patient involvement in syntheses
- Funding syntheses
- Evidence tools: Abstracts concerning guidelines and other knowledge translation methods and tools
- Priority setting for evidence tools to meet local and global priorities
- Evidence literacy, social media, science journalism
- Evidence tools for consumers and to promote shared decision making
- Evidence tools for policy makers and civil society
- Guideline development, adaptation, assessment and updating
- Health technology assessment
- Evidence implementation and evaluation: Abstracts concerning getting evidence into policy and practice
- Priority setting for implementation to meet local and global priorities
- Enhancing the implementability of evidence tools
- Design and evaluation of dissemination and implementation programs
- Quality improvement methods and performance measures
- Building capacity for dissemination and implementation
- Measuring policy and practice impact
- Advocating for evidence
Deadline for submission of abstracts is 1 March 2017.
How to submit an abstract
First you need to create a new account (you cannot reuse your login from a previous Cochrane Colloquium). You do not need to register for the Global Evidence Summit in order to submit an abstract.
Once logged in, you have access to the online submission form.
After successfully entering all the information required, you can preview your submission before saving it. You, or any other contact person listed for the abstract, can also view and edit the abstract, accessed via the ‘My submissions’ tab of your account page, up until the submission deadline of 1 March.
Instructions for oral and poster abstracts
- Abstracts must be submitted online by 1 March.
- Only abstracts submitted in English will be considered.
- Abstracts must not be longer than 2200 characters (approx. 300 words).
- Abstracts should be structured as follows: Background, Objectives, Methods, Results and Conclusions. If your abstract does not fit into this format, please choose alternative headings that are appropriate.
- The abstract title should not be longer than 20 words.
- If abbreviations are used, the abbreviated term should be written out in full the first time it is used.
- Tables and graphs can be submitted with your abstract as an attached image document. Allowed formats are: gif, png, jpg, jpeg, tif, tiff, pdf. Please remember to insert the reference (Table 1, Figure 1, etc.) in the abstract.
Submission of abstracts
You will receive an automated email to acknowledge your abstract submission. (Please allow up to 20 minutes to receive this email.) If you do not receive an email, or if you require any help with submitting your abstract, please email the Co-Chairs of the Abstract Sub-Committee at email@example.com.
Acceptance and notification of abstracts
Acceptance of abstracts into the conference programme will be determined by the relevance, originality, clarity and scientific quality of the submitted work by the abstract committee. At the time of submission you will be asked to indicate a preference for oral or poster presentation, however, the final decision on the type of presentation offered is made by the Abstract Sub-Committee. We aim to notify authors of acceptance or rejection of their submission by 1 May.
All presenters of accepted abstracts are required to register and attend the conference. The organizers reserve the right to withdraw abstracts if presenters have not registered for the Global Evidence Summit by 1 July.
The Abstracts Sub-Committee Co-Chairs are Solange Durao and Patricia Mc Inerney. They can be contacted at firstname.lastname@example.org.
Conference website: www.globalevidencesummit.org